Cargando…

TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD

Activation of thyroid hormone receptor β (THRβ) has shown beneficial effects on metabolic alterations, including non-alcoholic fatty liver disease (NAFLD). Here, we investigated the effect of TG68, a novel THRβ agonist, on fatty liver accumulation and liver injury in mice fed a high-fat diet (HFD)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Caddeo, Andrea, Kowalik, Marta Anna, Serra, Marina, Runfola, Massimiliano, Bacci, Andrea, Rapposelli, Simona, Columbano, Amedeo, Perra, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657920/ https://www.ncbi.nlm.nih.gov/pubmed/34884910 http://dx.doi.org/10.3390/ijms222313105

Ejemplares similares

Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis
por: Caddeo, Andrea, et al.
Publicado: (2023)

Potential role of two novel agonists of thyroid hormone receptor‐β on liver regeneration
por: Perra, Andrea, et al.
Publicado: (2020)

Thyroid Hormones, Thyromimetics and Their Metabolites in the Treatment of Liver Disease
por: Kowalik, Marta A., et al.
Publicado: (2018)

Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders
por: Saponaro, Federica, et al.
Publicado: (2020)

Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma
por: Serra, Marina, et al.
Publicado: (2020)

Synthetic Thyroid Hormone Receptor-β Agonists Promote Oligodendrocyte Precursor Cell Differentiation in the Presence of Inflammatory Challenges
por: Baldassarro, Vito Antonio, et al.
Publicado: (2023)

Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases
por: Bacci, Andrea, et al.
Publicado: (2021)

mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma
por: Serra, Marina, et al.
Publicado: (2022)

Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
por: Kowalik, Marta Anna, et al.
Publicado: (2017)

Diverse MicroRNAs‐mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia
por: Pal, Rajesh, et al.
Publicado: (2022)

Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma
por: Smiriglia, Alfredo, et al.
Publicado: (2023)

Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis
por: Kowalik, Marta Anna, et al.
Publicado: (2015)

Induction of autophagy promotes the growth of early preneoplastic rat liver nodules
por: Kowalik, Marta Anna, et al.
Publicado: (2015)

Design, Synthesis, and In Vitro Evaluation of Novel 8-Amino-Quinoline Combined with Natural Antioxidant Acids
por: Bacci, Andrea, et al.
Publicado: (2022)

Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease
por: Runfola, Massimiliano, et al.
Publicado: (2021)

Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
por: Orrù, Claudia, et al.
Publicado: (2020)

New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
por: Sestito, Simona, et al.
Publicado: (2018)

Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics
por: Runfola, Massimiliano, et al.
Publicado: (2020)

Editorial: Targeting Thyroid Hormone-Dependent Pathways in Proliferative and Degenerative Disorders
por: Perra, Andrea, et al.
Publicado: (2022)

Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC
por: Mattu, Sandra, et al.
Publicado: (2021)

Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism?
por: Serra, Marina, et al.
Publicado: (2020)

SUN-717 SG-2 a Novel Multi-Target Directed Ligand (MTDL) for the Treatment of Neurodegenerative Diseases (NDDS)
por: Sestito, Simona, et al.
Publicado: (2020)

Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
por: Kowalik, Marta Anna, et al.
Publicado: (2016)

Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD
por: Sinha, Rohit Anthony, et al.
Publicado: (2016)

The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD
por: Zhou, Jin, et al.
Publicado: (2021)

Sensitivity to Thyroid Hormone Indices Are Closely Associated With NAFLD
por: Lai, Shuiqing, et al.
Publicado: (2021)

Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis
por: Kim, Bokyung, et al.
Publicado: (2021)

The influence of thyroid status, serum Tg, TSH, and TgAb on FNA‐Tg in cervical metastatic lymph nodes of papillary thyroid carcinoma
por: Sun, Jingjing, et al.
Publicado: (2021)

Study on the independent effect of thyroid hormone based on uric acid level on NAFLD
por: Chao, Guanqun, et al.
Publicado: (2021)

A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis
por: Angioni, Maria Maddalena, et al.
Publicado: (2017)

Recent Developments in NAFLD
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH
por: Finan, Brian, et al.
Publicado: (2020)

Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6
por: Bellusci, Lorenza, et al.
Publicado: (2020)

Thyroid Hormone Receptor Agonist Promotes Hair Growth in Mice
por: Zhu, Peiqiu, et al.
Publicado: (2022)

Predictive Value of FNA-Tg and TgAb in Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma
por: Wu, Xiaoli, et al.
Publicado: (2022)

Treatments for NAFLD: State of Art
por: Mantovani, Alessandro, et al.
Publicado: (2021)

NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Thyroid Dysfunction after Gonadotropin-Releasing Hormone Agonist Administration in Women with Thyroid Autoimmunity
por: Marin, Loris, et al.
Publicado: (2022)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Changes in Thyroid Hormone Signaling Mediate Cardiac Dysfunction in the Tg197 Mouse Model of Arthritis: Potential Therapeutic Implications
por: Ntari, Lydia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_19328mpj2106au2j76iqblfj56